Randomized Study to Compare the Bioavailability of Three Halobetasol Propionate 0.05% Topical Creams
Status:
Completed
Trial end date:
2004-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this study was to compare the relative vasoconstrictive effects of two test
and one reference Halobetasol Propionate 0.05% Cream in healthy, female subjects.